Axio Biosolutions - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2008, Axio Biosolutions operates in Health Tech industry. Initially focused on creating hemostatic solutions, the company has expanded its product offerings to serve both trauma and surgica...
Funding stage:
Series B
Last funding:
26/07/2021
Total funding:
$20.90 Mn+
Revenue:
Investors
Employee count:
126
Last 90d
126
Last 90d
Web traffic:
7.75K
7.75K
Last 30d
Last 30d
Glassdoor Rating:
Axio Biosolutions: Funding Highlights
Funding highlights of Axio Biosolutions and a snapshot of its key metrics.
Total Funding$20.90 Mn+
Current StageGrowth Stage
Total Round(s)5
Funding Rounds
FAQs on Funding of Axio Biosolutions
Health Tech Funded Axio Biosolutions has raised a total funding of $20.90 million dollars as of 27 July 2021 across 5 rounds. Find the details around funding rounds, participating investors, and other insights of Axio Biosolutions here...
Axio Biosolutions has raised a total of $20.90 million dollars across 5 funding rounds and the last round was raised on 27 July 2021.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links